Alpine Global Management’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,923
Closed -$97.7K 359
2024
Q2
$97.7K Buy
+12,923
New +$130K 0.02% 411

Other funds holding NPCE

Alpine Global Management's NPCE Position: Q3 2024 in Review

Alpine Global Management sold out of Neuropace (NPCE) in Q3 2024, closing a stake of 12,923 shares — an estimated $97.7K sold.

Alpine Global Management first reported a position in NPCE in Q2 2024 and held it in 1 quarter. The position peaked at $97.7K in Q2 2024. 48 funds tracked by Wall St. Rank hold NPCE as of Q3 2024.

  • Alpine Global Management reported no remaining Neuropace position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 12,923 Neuropace shares in Q3 2024, an estimated $97.7K.
  • Alpine Global Management first reported a position in Neuropace in Q2 2024 and held it in 1 quarter.
  • Alpine Global Management's Neuropace position peaked at $97.7K in Q2 2024.
  • 48 funds tracked by Wall St. Rank held Neuropace as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.